N/A
Completed N=180
Efficacy Trial of a Dissonance Based Eating Disorder Program
Source: ClinicalTrials.gov NCT03796091 ↗Enrolled (actual)
180
Serious AEs
1.7%
Results posted
Dec 2022
Primary outcomePrimary: Rosenberg Self-Esteem Scale (RSE). — 22.71; 22.50; 22.62 units on a scale
Summary
The purpose of this clinical trial is to investigate whether symptoms of disordered eating change among participants who complete an intervention. Participants will be randomly assigned to one of three intervention conditions and will undergo assessments of symptoms before, after, and 2 months after each intervention. Investigators are evaluating which interventions are most effective in reducing eating disorder symptoms and disorder-related psychological and cardiac risk factors.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Rosenberg Self-Esteem Scale (RSE). |
24.55; 25.55; 26.60 | — |
| PRIMARY Eating Disorder Examination Questionnaire (EDE-Q). |
3.74; 2.73; 2.78 | — |
| PRIMARY Body Shape Questionnaire (BSQ). |
129.51; 105.19; 105.29 | — |
| PRIMARY Social Comparison Rating Scale (SCRS). |
46.28; 53.39; 53.18 | — |
| PRIMARY Self-Objectification Questionnaire (SOQ) |
9.80; 2.81; 1.78 | — |
| PRIMARY Ideal Body Stereotype Scale - Revised. |
3.76; 3.34; 3.46 | — |
| PRIMARY State Trait Anxiety Inventory - Form Y. |
55.63; 51.63; 52.58 | — |
| PRIMARY Positive and Negative Affect Scale - Positive Affect |
26.60; 27.84; 27.98 | — |
| PRIMARY Mean R Wave Amplitude |
1.26; 1.14; 1.12 | — |
| PRIMARY QT Interval Length |
.38; .38; .38 | — |
| PRIMARY Vagal Cardiac Tone - High Frequency Spectral Power |
51.65; 56.60; 58.81 | — |
| PRIMARY Sympathetic Cardiac Tone - Low Frequency High Frequency Spectral Power Ratio |
1.54; 1.86; 1.32 | — |
| PRIMARY Positive and Negative Affect Scale - Negative Affect |
28.50; 24.24; 25.00 | — |
Eligibility Criteria
Inclusion Criteria
- Inclusion Criteria
- Women
- Age 15-34
- Postmenarcheal
- Premenopausal
- Subclinical or Clinical Eating Disorder Symptoms
Exclusion Criteria
- Exclusion Criteria
- Must get physician clearance to participate if at medically high risk as defined in the protocol
- Must not be pregnant
- Must be able to read and speak English
Data sourced from ClinicalTrials.gov (NCT03796091). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.